Black Diamond Therapeutics, Inc. (BDTX) earnings
BDTX earnings moved a median of 0.00% by the close. Quarterly and annual BDTX reports and results, each read against the price at its own news timestamp. Back to the BDTX overview →
21 measured BDTX earnings events.
Where these BDTX earnings landedvs 21 measured BDTX earnings reactions
| Middle 50% of BDTX earnings reactions | -6.12% to +2.17% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 BDTX earnings events with a measured close landed between -6.12% and +2.17%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.83% | +6.67% | |
| Form 10-Q Black Diamond Therapeuti For: Jun 30 | SEC filing · Form 10-Q | +0.83% | +6.67% | |
| Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -4.72% | -1.80% | |
| Form 10-Q Black Diamond Therapeuti For: Mar 31 | SEC filing · Form 10-Q | -4.72% | -1.80% | |
| Form 10-K Black Diamond Therapeuti For: Dec 31 | SEC filing · Form 10-K | +4.72% | +5.19% | |
| Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.77% | +2.05% | |
| Form 10-Q Black Diamond Therapeuti For: Sep 30 | SEC filing · Form 10-Q | -0.77% | +2.05% | |
| Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -5.58% | -9.52% | |
| Form 10-Q Black Diamond Therapeuti For: Jun 30 | SEC filing · Form 10-Q | -5.58% | -9.52% | |
| Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | +1.05% | |
| Form 10-Q Black Diamond Therapeuti For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.05% | |
| Form 10-K Black Diamond Therapeuti For: Dec 31 | SEC filing · Form 10-K | -0.54% | +2.17% | |
| Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +4.79% | +3.83% | |
| Form 10-Q Black Diamond Therapeuti For: Sep 30 | SEC filing · Form 10-Q | +4.79% | +3.83% | |
| Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -4.66% | -6.62% | |
| Form 10-Q Black Diamond Therapeuti For: Jun 30 | SEC filing · Form 10-Q | -4.66% | -6.62% | |
| Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.42% | -6.12% | |
| Form 10-Q Black Diamond Therapeuti For: Mar 31 | SEC filing · Form 10-Q | +0.42% | -6.12% | |
| Form 10-K Black Diamond Therapeuti For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.79% | |
| Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +1.78% | +0.00% | |
| Form 10-Q Black Diamond Therapeuti For: Sep 30 | SEC filing · Form 10-Q | +1.78% | +0.00% |
Keep exploring
More BDTX: analyst actions → · SEC filings → · BDTX overview →